(Alliance News) - Shares in Mondi PLC on Monday tumbled after posting a "shocker" third-quarter operational performance. The Weybridge, England-based packaging firm shed 16% to 879.60 pence in London, ...

In European equities on Monday, the CAC 40 in Paris closed down 1.4%, while the DAX 40 in Frankfurt ended unchanged. The CAC 40 tumbled after Prime Minister Sebastien Lecornu resigned.

On Monday last week, Beacon Rise said entered non-binding heads of terms to acquire Ergotec for approximately GBP1.0 million. At this time, Beacon Rise said it was preliminary discussions with regard ...

(Alliance News) - Ananda Pharma PLC on Monday said the last patient has received their final MRX1 dose in the phase one pharmacokinetic study. Ananda is a London-based biopharmaceutical company that ...

Aeorema Communications PLC - London-based live events agency - Aeorema's Cheerful Twentyfirst brand experience agency has seen "consistent and continued momentum" in North America over the past three ...

The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News: SkinBioTherapeutics PLC - life science firm focused on skin health - ...

Active Energy expects the site, based on current deals, to deliver approximately USD3.5 million in annual revenue at an estimated 50% gross margin. It said this represents around USD1.75 million of ...

(Alliance News) - tinyBuild Inc on Monday maintained it was "is on track to deliver results at least in line with expectations," whilst noting its recent share price movement. The Seattle, ...

This will increase the deal's footprint to 19 US states, from the four states covered in the initial agreement. Ascend Imaging will continue to identify new prospective customers, drive engagement and ...

River UK Micro Cap Ltd on Monday said it outperformed its benchmark in the 12 months to the end of September. In a trading update, the London-based investment company focused on firms with market caps ...

(Alliance News) - Hemogenyx Pharmaceuticals PLC on Monday said it has received clearance to begin pediatric enrolment in its phase 1 trial of a leukemia treatment.

Fulcrum has been issued with 78.7 million common shares in Loyalist, as well as CAD500,000 in cash, which is about GBP266,344, and a 2.0% net smelter return royalty on the Tully project.